Global Tumor Ablation Market 2023-2029

March 2023 | 76 pages | ID: G8822762E43CEN
Gen Consulting Company

Abstracts

Tumor ablation is a minimally invasive medical procedure that is used to destroy cancer cells within tumors. This procedure involves the use of heat, cold, or chemicals to destroy cancer cells within tumors, which may be primary or metastatic. Tumor ablation is considered a minimally invasive procedure because it does not require surgery to access tumors. Instead, a small incision is made through the skin, and a special probe is inserted into the tumor to deliver the heat, cold, or chemicals used for ablation. Tumor ablation can be used in combination with other cancer treatments, such as chemotherapy or radiation therapy, to increase the effectiveness of cancer treatment. According to the latest estimates, the global tumor ablation market size is expected to increase from USD 919.0 million in 2022 to USD 1,939.5 million by 2029, garnering a CAGR of 11.26% over the evaluated period.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global tumor ablation market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the technology, treatment, application, end user, and region. The global market for tumor ablation can be segmented by technology: radiofrequency, microwave, irreversible electroporation, cryoablation, other. The radiofrequency segment was the largest contributor to the global tumor ablation market in 2022. Tumor ablation market is further segmented by treatment: surgical ablation, percutaneous ablation, laparoscopic ablation. According to the research, the surgical ablation segment had the largest share in the global tumor ablation market. Based on application, the tumor ablation market is segmented into: lung cancer, kidney cancer, liver cancer, others. The lung cancer segment held the largest revenue share in 2022. On the basis of end user, the tumor ablation market also can be divided into: hospitals and clinics, specialty centers, others. Globally, the hospitals and clinics segment made up the largest share of the tumor ablation market. Tumor ablation market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

Market Segmentation
By technology: radiofrequency, microwave, irreversible electroporation, cryoablation, other
By treatment: surgical ablation, percutaneous ablation, laparoscopic ablation
By application: lung cancer, kidney cancer, liver cancer, others
By end user: hospitals and clinics, specialty centers, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides analysis of the key companies of the industry and their detailed company profiles including Johnson & Johnson, Medtronic plc, Boston Scientific Corporation, SonaCare Medical, LLC, EDAP TMS SA, AngioDynamics, Inc., HealthTronics, Inc., Misonix, Inc., Biotronik, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
To analyze and forecast the market size of the global tumor ablation market.
To classify and forecast the global tumor ablation market based on technology, treatment, application, end user, region.
To identify drivers and challenges for the global tumor ablation market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global tumor ablation market.
To identify and analyze the profile of leading players operating in the global tumor ablation market.

Why Choose This Report
Gain a reliable outlook of the global tumor ablation market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY TECHNOLOGY

Radiofrequency
Microwave
Irreversible electroporation
Cryoablation
Other

PART 6. MARKET BREAKDOWN BY TREATMENT

Surgical ablation
Percutaneous ablation
Laparoscopic ablation

PART 7. MARKET BREAKDOWN BY APPLICATION

Lung cancer
Kidney cancer
Liver cancer
Others

PART 8. MARKET BREAKDOWN BY END USER

Hospitals and clinics
Specialty centers
Others

PART 9. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 10. KEY COMPANIES

Johnson & Johnson
Medtronic plc
Boston Scientific Corporation
SonaCare Medical, LLC
EDAP TMS SA
AngioDynamics, Inc.
HealthTronics, Inc.
Misonix, Inc.
Biotronik, Inc.

DISCLAIMER